cGMP and mitochondrial K⁺ channels-Compartmentalized but closely connected in cardioprotection

Area of Science:

• Cardiovascular Physiology
• Mitochondrial Biology
• Cellular Signalling

Background:

• Myocardial ischaemia and reperfusion (I/R) injury significantly impacts cardiomyocyte survival.
• The 3',5'-cyclic guanosine monophosphate (cGMP) pathway is known to trigger cytoprotective responses.
• Nitric oxide-sensitive guanylate cyclase (GC) induced cGMP production activates cGMP-dependent protein kinase I (cGKI).

Purpose of the Study:

• To summarize the infarct-limiting actions of the GC/cGMP pathway in the context of myocardial I/R injury.
• To discuss the role of mitochondrial potassium channels (mitoK_ATP and mitoBK) in conferring protection.
• To highlight the potential of targeting the cGMP pathway and mitoK⁺ channels as an adjunct therapy for myocardial infarction.

Main Methods:

• Review and synthesis of existing literature on the GC/cGMP pathway and its substrates.
• Analysis of the role of cGKI in phosphorylating key proteins involved in mitochondrial function.
• Discussion of the functional connection between cGMP signalling and mitoK_ATP /mitoBK channel activation.

Main Results:

• cGKI activation leads to the phosphorylation of substrates that facilitate the opening of mitoK_ATP and mitoBK channels.
• Activation of mitoK_ATP or mitoBK channels confers protection against I/R-induced cardiac damage.
• The GC/cGMP axis plays a crucial role in limiting infarct size by preserving cardiomyocyte viability.

Conclusions:

• The GC/cGMP pathway, through cGKI, protects cardiomyocytes during I/R injury by modulating mitochondrial function via mitoK_ATP and mitoBK channels.
• Targeting the interplay between the cGMP cascade and mitochondrial potassium channels represents a viable therapeutic strategy.
• Exploiting this functional connection could significantly enhance reperfusion therapy for myocardial infarction.